Tatva Chintan Pharma Chem Ltd.
•₹ 1,616.4-1.34%
2026-08-21
ABOUT
KEY POINTS
Revenue Breakup Mar 2025 • Pharmaceutical & Agrochemical intermediates & Other Specialty Chemicals: 34.3% • Structure Directing Agents: 33.7% • Phase Transfer Catalysts: 30.1% • Electrolyte Salts: 1.2% • Other Operating Revenue: 0.8%
PROS
- Company is almost debt free
- Latest quarter profit grew 103.6% YoY, showing strong momentum
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.14x)
- Working capital cycle has improved - days down from 198 to 151
- Company has a consistent dividend-paying track record
CONS
- A large part of profit comes from other income (772.5% of PBT)
- Company has a low return on capital employed of 4.9%
- Company has a low return on equity of 4.4% over last 3 years
- Interest coverage is weak at 1.3x - earnings barely cover interest
- Receivables are growing faster than sales - a possible quality concern
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SOLARINDS | 19800.00 | 89.97 | 179170.31 | 0.06 | 666.37 | 88.98 | 3668.20 | 70.26 | 38.16 | 27.91 |
| 2. | PIDILITIND | 1650.00 | 63.40 | 167935.41 | 1.30 | 8835.10 | 1202.86 | 45515.50 | 1112.74 | 32.38 | 26.28 |
| 3. | SRF | 2575.00 | 35.31 | 76329.39 | 0.35 | 758.87 | 75.53 | 5033.26 | 34.63 | 14.21 | 24.57 |
| 4. | FLUOROCHEM | 4679.55 | 83.59 | 51404.86 | 0.06 | 219.00 | 19.02 | 1588.00 | 23.97 | 10.02 | 26.83 |
| 5. | NAVINFLUOR | 8281.50 | 53.80 | 42484.11 | 0.18 | 243.31 | 107.67 | 1045.08 | 44.07 | 21.39 | 34.17 |
| 6. | GODREJIND | 1217.10 | 34.87 | 40998.14 | 0.00 | 523.36 | -27.85 | 5448.09 | 22.16 | 10.64 | 12.82 |
| 7. | DEEPAKNTR | 1767.85 | 30.78 | 24112.24 | 0.42 | 345.01 | 207.36 | 2577.60 | 36.39 | 11.58 | 20.96 |
| 8. | AETHER | 1639.40 | 92.52 | 21759.40 | 0.00 | 62.75 | 33.45 | 326.56 | 27.49 | 11.65 | 31.47 |
| 9. | ATUL | 6581.75 | 24.36 | 19377.83 | 0.46 | 253.93 | 91.85 | 1847.95 | 25.03 | 15.05 | 21.41 |
| 10. | AARTIIND | 526.90 | 35.99 | 19112.07 | 0.19 | 155.00 | 260.47 | 2387.00 | 42.42 | 6.39 | 16.00 |
| 11. | DEEPAKFERT | 1474.65 | 18.98 | 18678.34 | 0.68 | 490.04 | 100.95 | 3256.26 | 22.47 | 12.12 | 25.96 |
| 12. | TATVA | 1647.40 | 75.00 | 3853.61 | 0.12 | 15.98 | 140.28 | 167.06 | 42.95 | 1.19 | 19.33 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106 | 93 | 86 | 94 | 94 | 81 | 84 | 108 | 109 | 116 | 139 | 133 | 147 | |
| 86 | 72 | 74 | 80 | 86 | 76 | 78 | 100 | 94 | 95 | 112 | 106 | 135 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 1 | 1 | 1 | 5 | 1 | 1 | 0 | 1 | 1 | 1 | 2 | -0 | 4 |
| Interest | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 |
| Depreciation | 6 | 7 | 7 | 6 | 7 | 7 | 7 | 7 | 9 | 9 | 9 | 10 | 11 |
| 12 | 12 | 7 | 12 | 2 | -2 | -2 | 2 | 7 | 12 | 19 | 15 | 14 | |
| Tax % | 29.61% | 29.89% | 29.12% | 32.82% | 29.44% | 29.75% | 29.70% | 29.68% | 27.23% | 27.55% | 14.95% | 39.72% | 25.88% |
| Net Profit | 8 | 8 | 5 | 8 | 2 | -1 | -1 | 1 | 5 | 9 | 16 | 9 | 10 |
| 4 | 4 | 2 | 4 | 1 | -0 | -0 | 0 | 2 | 4 | 7 | 4 | 0 | |
| Equity Capital | 22 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 22 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 106
- 86
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 3
- Depreciation
- 6
- 12
- Tax %
- 29.61%
- Net Profit
- 8
- 4
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 93
- 72
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 3
- Depreciation
- 7
- 12
- Tax %
- 29.89%
- Net Profit
- 8
- 4
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 86
- 74
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 7
- 7
- Tax %
- 29.12%
- Net Profit
- 5
- 2
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 94
- 80
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 0
- Depreciation
- 6
- 12
- Tax %
- 32.82%
- Net Profit
- 8
- 4
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 94
- 86
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 7
- 2
- Tax %
- 29.44%
- Net Profit
- 2
- 1
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 81
- 76
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 7
- -2
- Tax %
- 29.75%
- Net Profit
- -1
- -0
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 84
- 78
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 7
- -2
- Tax %
- 29.70%
- Net Profit
- -1
- -0
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 108
- 100
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 7
- 2
- Tax %
- 29.68%
- Net Profit
- 1
- 0
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 109
- 94
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 9
- 7
- Tax %
- 27.23%
- Net Profit
- 5
- 2
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 116
- 95
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 9
- 12
- Tax %
- 27.55%
- Net Profit
- 9
- 4
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 139
- 112
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 0
- Depreciation
- 9
- 19
- Tax %
- 14.95%
- Net Profit
- 16
- 7
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 133
- 106
- Operating Profit
- —
- OPM %
- —
- Other Income
- -0
- Interest
- 1
- Depreciation
- 10
- 15
- Tax %
- 39.72%
- Net Profit
- 9
- 4
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 147
- 135
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 2
- Depreciation
- 11
- 14
- Tax %
- 25.88%
- Net Profit
- 10
- 0
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 23
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 90 | 109 | 129 | 203 | 254 | 291 | 428 | 403 | 379 | 366 | 534 | |
| 75 | 83 | 109 | 170 | 201 | 226 | 322 | 348 | 312 | 340 | 448 | |
| Operating Profit | 16 | 31 | 25 | 34 | 53 | 70 | 117 | 60 | 75 | 30 | — |
| OPM % | 17 | 29 | 20 | 17 | 21 | 24 | 27 | 15 | 20 | 8 | — |
| Other Income | 1 | 5 | 5 | 0 | 1 | 5 | 11 | 6 | 8 | 4 | 6 |
| Interest | 2 | 2 | 3 | 4 | 4 | 4 | 5 | 9 | 7 | 1 | 5 |
| Depreciation | 2 | 2 | 4 | 4 | 5 | 7 | 8 | 10 | 26 | 28 | 38 |
| 12 | 27 | 18 | 26 | 44 | 59 | 103 | 39 | 42 | 0 | 60 | |
| Tax % | 36 | 37 | 35 | 24 | 21 | 13 | 7 | -4 | 31 | 29 | 26 |
| Net Profit | 7 | 17 | 12 | 20 | 35 | 51 | 96 | 40 | 29 | 0 | 44 |
| EPS | 9 | 22 | 15 | 10 | 17 | 26 | 45 | 18 | 13 | 0 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 20 | 5 | 11 | 16 | 715 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 4 | 9 | 6 | 10 | 17 | 26 | 43 | 18 | 13 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 4 | 9 | 6 | 10 | 17 | 26 | 43 | 18 | 13 | 0 | — |
Mar 2016
- 90
- 75
- Operating Profit
- 16
- OPM %
- 17
- Other Income
- 1
- Interest
- 2
- Depreciation
- 2
- 12
- Tax %
- 36
- Net Profit
- 7
- EPS
- 9
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2017
- 109
- 83
- Operating Profit
- 31
- OPM %
- 29
- Other Income
- 5
- Interest
- 2
- Depreciation
- 2
- 27
- Tax %
- 37
- Net Profit
- 17
- EPS
- 22
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2018
- 129
- 109
- Operating Profit
- 25
- OPM %
- 20
- Other Income
- 5
- Interest
- 3
- Depreciation
- 4
- 18
- Tax %
- 35
- Net Profit
- 12
- EPS
- 15
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2019
- 203
- 170
- Operating Profit
- 34
- OPM %
- 17
- Other Income
- 0
- Interest
- 4
- Depreciation
- 4
- 26
- Tax %
- 24
- Net Profit
- 20
- EPS
- 10
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
Mar 2020
- 254
- 201
- Operating Profit
- 53
- OPM %
- 21
- Other Income
- 1
- Interest
- 4
- Depreciation
- 5
- 44
- Tax %
- 21
- Net Profit
- 35
- EPS
- 17
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 17
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 17
Mar 2021
- 291
- 226
- Operating Profit
- 70
- OPM %
- 24
- Other Income
- 5
- Interest
- 4
- Depreciation
- 7
- 59
- Tax %
- 13
- Net Profit
- 51
- EPS
- 26
- Dividend Payout %
- 20
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 26
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 26
Mar 2022
- 428
- 322
- Operating Profit
- 117
- OPM %
- 27
- Other Income
- 11
- Interest
- 5
- Depreciation
- 8
- 103
- Tax %
- 7
- Net Profit
- 96
- EPS
- 45
- Dividend Payout %
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 43
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 43
Mar 2023
- 403
- 348
- Operating Profit
- 60
- OPM %
- 15
- Other Income
- 6
- Interest
- 9
- Depreciation
- 10
- 39
- Tax %
- -4
- Net Profit
- 40
- EPS
- 18
- Dividend Payout %
- 11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 18
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 18
Mar 2024
- 379
- 312
- Operating Profit
- 75
- OPM %
- 20
- Other Income
- 8
- Interest
- 7
- Depreciation
- 26
- 42
- Tax %
- 31
- Net Profit
- 29
- EPS
- 13
- Dividend Payout %
- 16
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
Mar 2025
- 366
- 340
- Operating Profit
- 30
- OPM %
- 8
- Other Income
- 4
- Interest
- 1
- Depreciation
- 28
- 0
- Tax %
- 29
- Net Profit
- 0
- EPS
- 0
- Dividend Payout %
- 715
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
TTM
- 534
- 448
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 5
- Depreciation
- 38
- 60
- Tax %
- 26
- Net Profit
- 44
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 14%
- 5 Years:
- 8%
- 3 Years:
- -5%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- -25%
- 5 Years:
- -61%
- 3 Years:
- -85%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- -6%
- 3 Years:
- -1%
- 1 Year:
- 48%
RETURN ON EQUITY
- 10 Years:
- 24%
- 5 Years:
- 16%
- 3 Years:
- 4%
- Last Year:
- 0%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 20 | 22 | 22 | 23 | 23 |
| 24 | 41 | 53 | 72 | 106 | 142 | 447 | 483 | 702 | 698 | |
| 17 | 29 | 36 | 40 | 40 | 63 | 107 | 166 | 10 | 36 | |
| Trade Payables | 15 | 18 | 24 | 22 | 31 | 47 | 44 | 32 | 44 | 32 |
| 7 | 26 | 25 | 46 | 59 | 47 | 48 | 38 | 23 | 21 | |
| Total Liabilities | 71 | 123 | 146 | 187 | 245 | 320 | 667 | 740 | 803 | 811 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 14 | 13 | 56 | 67 | 111 | 120 | 160 | 196 | 427 | 529 | |
| Capital Work in Progress | 5 | 27 | 10 | 6 | 5 | 10 | 51 | 231 | 73 | 22 |
| 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 11 | 1 | |
| 18 | 20 | 24 | 31 | 59 | 68 | 161 | 151 | 144 | 123 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68 | 76 | |
| Cash & Bank | 4 | 18 | 8 | 16 | 10 | 4 | 175 | 39 | 37 | 12 |
| 30 | 43 | 46 | 67 | 60 | 117 | 120 | 123 | 43 | 48 | |
| Total Assets | 71 | 123 | 146 | 187 | 245 | 320 | 667 | 740 | 803 | 811 |
| Total Debt | 21 | 46 | 56 | 77 | 91 | 90 | 120 | 170 | 14 | 36 |
| Net Working Capital | 14 | 20 | 15 | 41 | 41 | 62 | 260 | 63 | 206 | 151 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 1 | 6 | 5 |
| Book Value per Share | 40.34 | 61.64 | 75.58 | 99.11 | 142.44 | 80.61 | 211.54 | 227.74 | 310.31 | 308.36 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 21 | 46 | 56 | 77 | 91 | 90 | 120 | 170 | 14 | 36 |
| Net Working Capital | 14 | 20 | 15 | 41 | 41 | 62 | 260 | 63 | 206 | 151 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 1 | 6 | 5 |
| Book Value per Share | 40.34 | 61.64 | 75.58 | 99.11 | 142.44 | 80.61 | 211.54 | 227.74 | 310.31 | 308.36 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2016
- Equity Capital
- 8
- 24
- 17
- Trade Payables
- 15
- 7
- Total Liabilities
- 71
- 14
- Capital Work in Progress
- 5
- 1
- 18
- 0
- Cash & Bank
- 4
- 30
- Total Assets
- 71
- Total Debt
- 21
- Net Working Capital
- 14
- Contingent Liabilities
- 0
- Book Value per Share
- 40.34
- Face Value
- 10.00
- Total Debt
- 21
- Net Working Capital
- 14
- Contingent Liabilities
- 0
- Book Value per Share
- 40.34
- Face Value
- 10.00
Mar 2017
- Equity Capital
- 8
- 41
- 29
- Trade Payables
- 18
- 26
- Total Liabilities
- 123
- 13
- Capital Work in Progress
- 27
- 1
- 20
- 0
- Cash & Bank
- 18
- 43
- Total Assets
- 123
- Total Debt
- 46
- Net Working Capital
- 20
- Contingent Liabilities
- 0
- Book Value per Share
- 61.64
- Face Value
- 10.00
- Total Debt
- 46
- Net Working Capital
- 20
- Contingent Liabilities
- 0
- Book Value per Share
- 61.64
- Face Value
- 10.00
Mar 2018
- Equity Capital
- 8
- 53
- 36
- Trade Payables
- 24
- 25
- Total Liabilities
- 146
- 56
- Capital Work in Progress
- 10
- 2
- 24
- 0
- Cash & Bank
- 8
- 46
- Total Assets
- 146
- Total Debt
- 56
- Net Working Capital
- 15
- Contingent Liabilities
- 0
- Book Value per Share
- 75.58
- Face Value
- 10.00
- Total Debt
- 56
- Net Working Capital
- 15
- Contingent Liabilities
- 0
- Book Value per Share
- 75.58
- Face Value
- 10.00
Mar 2019
- Equity Capital
- 8
- 72
- 40
- Trade Payables
- 22
- 46
- Total Liabilities
- 187
- 67
- Capital Work in Progress
- 6
- 1
- 31
- 0
- Cash & Bank
- 16
- 67
- Total Assets
- 187
- Total Debt
- 77
- Net Working Capital
- 41
- Contingent Liabilities
- 0
- Book Value per Share
- 99.11
- Face Value
- 10.00
- Total Debt
- 77
- Net Working Capital
- 41
- Contingent Liabilities
- 0
- Book Value per Share
- 99.11
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 8
- 106
- 40
- Trade Payables
- 31
- 59
- Total Liabilities
- 245
- 111
- Capital Work in Progress
- 5
- 1
- 59
- 0
- Cash & Bank
- 10
- 60
- Total Assets
- 245
- Total Debt
- 91
- Net Working Capital
- 41
- Contingent Liabilities
- 1
- Book Value per Share
- 142.44
- Face Value
- 10.00
- Total Debt
- 91
- Net Working Capital
- 41
- Contingent Liabilities
- 1
- Book Value per Share
- 142.44
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 20
- 142
- 63
- Trade Payables
- 47
- 47
- Total Liabilities
- 320
- 120
- Capital Work in Progress
- 10
- 1
- 68
- 0
- Cash & Bank
- 4
- 117
- Total Assets
- 320
- Total Debt
- 90
- Net Working Capital
- 62
- Contingent Liabilities
- 1
- Book Value per Share
- 80.61
- Face Value
- 10.00
- Total Debt
- 90
- Net Working Capital
- 62
- Contingent Liabilities
- 1
- Book Value per Share
- 80.61
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 22
- 447
- 107
- Trade Payables
- 44
- 48
- Total Liabilities
- 667
- 160
- Capital Work in Progress
- 51
- 1
- 161
- 0
- Cash & Bank
- 175
- 120
- Total Assets
- 667
- Total Debt
- 120
- Net Working Capital
- 260
- Contingent Liabilities
- 3
- Book Value per Share
- 211.54
- Face Value
- 10.00
- Total Debt
- 120
- Net Working Capital
- 260
- Contingent Liabilities
- 3
- Book Value per Share
- 211.54
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 22
- 483
- 166
- Trade Payables
- 32
- 38
- Total Liabilities
- 740
- 196
- Capital Work in Progress
- 231
- 1
- 151
- 0
- Cash & Bank
- 39
- 123
- Total Assets
- 740
- Total Debt
- 170
- Net Working Capital
- 63
- Contingent Liabilities
- 1
- Book Value per Share
- 227.74
- Face Value
- 10.00
- Total Debt
- 170
- Net Working Capital
- 63
- Contingent Liabilities
- 1
- Book Value per Share
- 227.74
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 23
- 702
- 10
- Trade Payables
- 44
- 23
- Total Liabilities
- 803
- 427
- Capital Work in Progress
- 73
- 11
- 144
- 68
- Cash & Bank
- 37
- 43
- Total Assets
- 803
- Total Debt
- 14
- Net Working Capital
- 206
- Contingent Liabilities
- 6
- Book Value per Share
- 310.31
- Face Value
- 10.00
- Total Debt
- 14
- Net Working Capital
- 206
- Contingent Liabilities
- 6
- Book Value per Share
- 310.31
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 23
- 698
- 36
- Trade Payables
- 32
- 21
- Total Liabilities
- 811
- 529
- Capital Work in Progress
- 22
- 1
- 123
- 76
- Cash & Bank
- 12
- 48
- Total Assets
- 811
- Total Debt
- 36
- Net Working Capital
- 151
- Contingent Liabilities
- 5
- Book Value per Share
- 308.36
- Face Value
- 10.00
- Total Debt
- 36
- Net Working Capital
- 151
- Contingent Liabilities
- 5
- Book Value per Share
- 308.36
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 | 24 | 13 | 8 | 25 | 19 | 20 | 24 | 103 | 24 | |
| Cash from Investing | -8 | -25 | -24 | -17 | -40 | -21 | -197 | -101 | -121 | -65 |
| Cash from Financing | 1 | 15 | 1 | 17 | 10 | -5 | 235 | 38 | 31 | 17 |
| 1 | 15 | -10 | 8 | -6 | -6 | 58 | -40 | 13 | -25 | |
| Free Cash Flow | 2 | 2 | -17 | 8 | -23 | -2 | -69 | -201 | 4 | -54 |
| OCF / Net Profit | 1.17 | 1.41 | 1.08 | 0.39 | 0.70 | 0.37 | 0.21 | 0.59 | 3.50 | 73.10 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -29 | -33 | -104 | -288 | -292 | -322 |
| OCF / Net Profit | 1.17 | 1.41 | 1.08 | 0.39 | 0.70 | 0.37 | 0.21 | 0.59 | 3.50 | 73.10 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -29 | -33 | -104 | -288 | -292 | -322 |
Mar 2016
- 9
- Cash from Investing
- -8
- Cash from Financing
- 1
- 1
- Free Cash Flow
- 2
- OCF / Net Profit
- 1.17
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.17
- Cumulative 5-Year FCF
- 0
Mar 2017
- 24
- Cash from Investing
- -25
- Cash from Financing
- 15
- 15
- Free Cash Flow
- 2
- OCF / Net Profit
- 1.41
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.41
- Cumulative 5-Year FCF
- 0
Mar 2018
- 13
- Cash from Investing
- -24
- Cash from Financing
- 1
- -10
- Free Cash Flow
- -17
- OCF / Net Profit
- 1.08
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.08
- Cumulative 5-Year FCF
- 0
Mar 2019
- 8
- Cash from Investing
- -17
- Cash from Financing
- 17
- 8
- Free Cash Flow
- 8
- OCF / Net Profit
- 0.39
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.39
- Cumulative 5-Year FCF
- 0
Mar 2020
- 25
- Cash from Investing
- -40
- Cash from Financing
- 10
- -6
- Free Cash Flow
- -23
- OCF / Net Profit
- 0.70
- Cumulative 5-Year FCF
- -29
- OCF / Net Profit
- 0.70
- Cumulative 5-Year FCF
- -29
Mar 2021
- 19
- Cash from Investing
- -21
- Cash from Financing
- -5
- -6
- Free Cash Flow
- -2
- OCF / Net Profit
- 0.37
- Cumulative 5-Year FCF
- -33
- OCF / Net Profit
- 0.37
- Cumulative 5-Year FCF
- -33
Mar 2022
- 20
- Cash from Investing
- -197
- Cash from Financing
- 235
- 58
- Free Cash Flow
- -69
- OCF / Net Profit
- 0.21
- Cumulative 5-Year FCF
- -104
- OCF / Net Profit
- 0.21
- Cumulative 5-Year FCF
- -104
Mar 2023
- 24
- Cash from Investing
- -101
- Cash from Financing
- 38
- -40
- Free Cash Flow
- -201
- OCF / Net Profit
- 0.59
- Cumulative 5-Year FCF
- -288
- OCF / Net Profit
- 0.59
- Cumulative 5-Year FCF
- -288
Mar 2024
- 103
- Cash from Investing
- -121
- Cash from Financing
- 31
- 13
- Free Cash Flow
- 4
- OCF / Net Profit
- 3.50
- Cumulative 5-Year FCF
- -292
- OCF / Net Profit
- 3.50
- Cumulative 5-Year FCF
- -292
Mar 2025
- 24
- Cash from Investing
- -65
- Cash from Financing
- 17
- -25
- Free Cash Flow
- -54
- OCF / Net Profit
- 73.10
- Cumulative 5-Year FCF
- -322
- OCF / Net Profit
- 73.10
- Cumulative 5-Year FCF
- -322
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 9.24 | 21.54 | 14.82 | 25.12 | 43.51 | 25.57 | 43.31 | 18.26 | 12.55 | 0.14 |
| Book Value (₹) | 40.34 | 61.64 | 75.58 | 99.11 | 142.44 | 80.61 | 211.54 | 227.74 | 310.31 | 308.36 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.00 | 2.00 | 2.00 | 2.00 | 1.00 |
| Cash EPS (₹) | 4.79 | 9.69 | 7.71 | 12.05 | 19.79 | 28.92 | 47.00 | 22.57 | 23.49 | 11.96 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 16.02% | 26.92% | 19.55% | 16.57% | 20.98% | 24.18% | 27.25% | 14.97% | 17.65% | 7.09% |
| Net Margin % | 7.62% | 14.91% | 9.20% | 9.95% | 13.77% | 17.62% | 22.42% | 10.01% | 7.73% | 0.09% |
| ROE % | 25.86% | 42.25% | 21.61% | 28.76% | 36.03% | 37.16% | 30.43% | 8.31% | 4.77% | 0.05% |
| ROCE % | 27.42% | 38.98% | 20.43% | 22.19% | 26.78% | 27.88% | 25.79% | 7.49% | 6.91% | 0.26% |
| 10.90% | 17.82% | 8.86% | 12.10% | 16.16% | 18.18% | 19.44% | 5.75% | 3.80% | 0.04% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 83 | 76 | 91 | 72 | 69 | 88 | 65 | 68 | 76 | 72 |
| Inventory Days | 58 | 61 | 63 | 50 | 65 | 80 | 98 | 141 | 142 | 133 |
| Payable Days | 131 | 118 | 114 | 73 | 75 | 96 | 85 | 62 | 82 | 71 |
| 10 | 18 | 40 | 49 | 59 | 72 | 78 | 147 | 136 | 134 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.65x | 0.93x | 0.92x | 0.97x | 0.79x | 0.56x | 0.26x | 0.34x | 0.02x | 0.05x |
| Interest Coverage (x) | 7.49x | 16.66x | 6.51x | 7.71x | 11.40x | 14.45x | 20.90x | 5.56x | 7.35x | 1.32x |
| 1.41x | 1.37x | 1.24x | 1.57x | 1.47x | 1.48x | 2.34x | 1.26x | 3.37x | 2.51x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | -11.46% | 20.96% | 18.99% | 56.77% | 25.10% | 14.71% | 46.92% | -5.79% | -6.05% | -3.24% |
| Operating Profit Growth % | 22.98% | 100.10% | -19.03% | 32.90% | 58.37% | 32.36% | 65.46% | -48.13% | 23.19% | -60.33% |
| Net Profit Growth % | 31.32% | 133.13% | -31.19% | 69.46% | 73.20% | 46.90% | 86.89% | -57.84% | -27.47% | -98.89% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -31.28% | -98.89% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 86.05x | 4856.88x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 3.48x | 2.20x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.19% | 0.15% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 33.58x | 54.54x |
Mar 2016
- EPS (₹)
- 9.24
- Book Value (₹)
- 40.34
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.79
- Operating Margin %
- 16.02%
- Net Margin %
- 7.62%
- ROE %
- 25.86%
- ROCE %
- 27.42%
- 10.90%
- Debtor Days
- 83
- Inventory Days
- 58
- Payable Days
- 131
- 10
- Debt to Equity (x)
- 0.65x
- Interest Coverage (x)
- 7.49x
- 1.41x
- Revenue Growth %
- -11.46%
- Operating Profit Growth %
- 22.98%
- Net Profit Growth %
- 31.32%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2017
- EPS (₹)
- 21.54
- Book Value (₹)
- 61.64
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 9.69
- Operating Margin %
- 26.92%
- Net Margin %
- 14.91%
- ROE %
- 42.25%
- ROCE %
- 38.98%
- 17.82%
- Debtor Days
- 76
- Inventory Days
- 61
- Payable Days
- 118
- 18
- Debt to Equity (x)
- 0.93x
- Interest Coverage (x)
- 16.66x
- 1.37x
- Revenue Growth %
- 20.96%
- Operating Profit Growth %
- 100.10%
- Net Profit Growth %
- 133.13%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 14.82
- Book Value (₹)
- 75.58
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 7.71
- Operating Margin %
- 19.55%
- Net Margin %
- 9.20%
- ROE %
- 21.61%
- ROCE %
- 20.43%
- 8.86%
- Debtor Days
- 91
- Inventory Days
- 63
- Payable Days
- 114
- 40
- Debt to Equity (x)
- 0.92x
- Interest Coverage (x)
- 6.51x
- 1.24x
- Revenue Growth %
- 18.99%
- Operating Profit Growth %
- -19.03%
- Net Profit Growth %
- -31.19%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 25.12
- Book Value (₹)
- 99.11
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 12.05
- Operating Margin %
- 16.57%
- Net Margin %
- 9.95%
- ROE %
- 28.76%
- ROCE %
- 22.19%
- 12.10%
- Debtor Days
- 72
- Inventory Days
- 50
- Payable Days
- 73
- 49
- Debt to Equity (x)
- 0.97x
- Interest Coverage (x)
- 7.71x
- 1.57x
- Revenue Growth %
- 56.77%
- Operating Profit Growth %
- 32.90%
- Net Profit Growth %
- 69.46%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 43.51
- Book Value (₹)
- 142.44
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 19.79
- Operating Margin %
- 20.98%
- Net Margin %
- 13.77%
- ROE %
- 36.03%
- ROCE %
- 26.78%
- 16.16%
- Debtor Days
- 69
- Inventory Days
- 65
- Payable Days
- 75
- 59
- Debt to Equity (x)
- 0.79x
- Interest Coverage (x)
- 11.40x
- 1.47x
- Revenue Growth %
- 25.10%
- Operating Profit Growth %
- 58.37%
- Net Profit Growth %
- 73.20%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 25.57
- Book Value (₹)
- 80.61
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 28.92
- Operating Margin %
- 24.18%
- Net Margin %
- 17.62%
- ROE %
- 37.16%
- ROCE %
- 27.88%
- 18.18%
- Debtor Days
- 88
- Inventory Days
- 80
- Payable Days
- 96
- 72
- Debt to Equity (x)
- 0.56x
- Interest Coverage (x)
- 14.45x
- 1.48x
- Revenue Growth %
- 14.71%
- Operating Profit Growth %
- 32.36%
- Net Profit Growth %
- 46.90%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 43.31
- Book Value (₹)
- 211.54
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 47.00
- Operating Margin %
- 27.25%
- Net Margin %
- 22.42%
- ROE %
- 30.43%
- ROCE %
- 25.79%
- 19.44%
- Debtor Days
- 65
- Inventory Days
- 98
- Payable Days
- 85
- 78
- Debt to Equity (x)
- 0.26x
- Interest Coverage (x)
- 20.90x
- 2.34x
- Revenue Growth %
- 46.92%
- Operating Profit Growth %
- 65.46%
- Net Profit Growth %
- 86.89%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 18.26
- Book Value (₹)
- 227.74
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 22.57
- Operating Margin %
- 14.97%
- Net Margin %
- 10.01%
- ROE %
- 8.31%
- ROCE %
- 7.49%
- 5.75%
- Debtor Days
- 68
- Inventory Days
- 141
- Payable Days
- 62
- 147
- Debt to Equity (x)
- 0.34x
- Interest Coverage (x)
- 5.56x
- 1.26x
- Revenue Growth %
- -5.79%
- Operating Profit Growth %
- -48.13%
- Net Profit Growth %
- -57.84%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 12.55
- Book Value (₹)
- 310.31
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 23.49
- Operating Margin %
- 17.65%
- Net Margin %
- 7.73%
- ROE %
- 4.77%
- ROCE %
- 6.91%
- 3.80%
- Debtor Days
- 76
- Inventory Days
- 142
- Payable Days
- 82
- 136
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 7.35x
- 3.37x
- Revenue Growth %
- -6.05%
- Operating Profit Growth %
- 23.19%
- Net Profit Growth %
- -27.47%
- -31.28%
- P/E (x)
- 86.05x
- P/B (x)
- 3.48x
- Dividend Yield %
- 0.19%
- 33.58x
Mar 2025
- EPS (₹)
- 0.14
- Book Value (₹)
- 308.36
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 11.96
- Operating Margin %
- 7.09%
- Net Margin %
- 0.09%
- ROE %
- 0.05%
- ROCE %
- 0.26%
- 0.04%
- Debtor Days
- 72
- Inventory Days
- 133
- Payable Days
- 71
- 134
- Debt to Equity (x)
- 0.05x
- Interest Coverage (x)
- 1.32x
- 2.51x
- Revenue Growth %
- -3.24%
- Operating Profit Growth %
- -60.33%
- Net Profit Growth %
- -98.89%
- -98.89%
- P/E (x)
- 4856.88x
- P/B (x)
- 2.20x
- Dividend Yield %
- 0.15%
- 54.54x
Documents
Announcements
- Resignation of Director/KMP/SMP
2026-08-19 - Tatva Chintan Pharma Chem Limited has informed the Exchange about Resignation of Director/KMP/SMP
- Resignation
2026-08-19 - Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Resignation of a Senior Management Personnel of the Company.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Jul 2026
May 2026
Jan 2026